{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T06:48:16Z","timestamp":1774766896013,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijid.2024.107096","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:30:06Z","timestamp":1715441406000},"page":"107096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rapid decrease in IL-1Ra and IP-10 plasma levels following tuberculosis treatment initiation"],"prefix":"10.1016","volume":"145","author":[{"given":"Polidy","family":"Pean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roseline","family":"Affi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine","family":"Chazalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben Cheick","family":"Soumahoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Gabillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunnet","family":"Dim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Borand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul","family":"Moh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Anglaret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7644-2188","authenticated-orcid":false,"given":"Fran\u00e7ois-Xavier","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Marie","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guislaine","family":"Carcelain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Laureillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3213-2692","authenticated-orcid":false,"given":"Laurence","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107096_bib0001","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cmi.2023.12.027","article-title":"Tuberculosis treatment monitoring tests during routine practice: study design guidance","volume":"30","author":"MacLean","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2024.107096_bib0002","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1016\/S0021-9258(18)99230-6","article-title":"Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction","volume":"266","author":"Dripps","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijid.2024.107096_bib0003","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","article-title":"Plasma soluble CD163 level independently predicts all-cause mortality in HIV-1-infected individuals","volume":"214","author":"Knudsen","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107096_bib0004","doi-asserted-by":"crossref","first-page":"14302","DOI":"10.1038\/s41598-017-13785-3","article-title":"IP-10 kinetics in the first week of therapy are strongly associated with bacteriological confirmation of tuberculosis diagnosis in HIV-infected patients","volume":"7","author":"Garc\u00eda-Basteiro","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2024.107096_bib0005","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jinf.2017.01.016","article-title":"Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV\/TB co-infected patients","volume":"74","author":"Nouhin","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2024.107096_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01859-21","article-title":"Biomarkers that correlate with active pulmonary tuberculosis treatment response: a systematic review and meta-analysis","volume":"60","author":"Zimmer","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2024.107096_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9112291","article-title":"Dynamics of plasmatic levels of pro- and anti-inflammatory cytokines in HIV-infected individuals with M. tuberculosis co-infection","volume":"9","author":"Nosik","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijid.2024.107096_bib0008","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The innate immune response to Mycobacterium tuberculosis infection","volume":"39","author":"Ravesloot-Ch\u00e1vez","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ijid.2024.107096_bib0009","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41598-022-26823-6","article-title":"Identification of host biomarkers from dried blood spots for monitoring treatment response in extrapulmonary tuberculosis","volume":"13","author":"Khalid","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2024.107096_bib0010","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1038\/s41598-020-65043-8","article-title":"RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response","volume":"10","author":"Penn-Nicholson","year":"2020","journal-title":"Sci Rep"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122400167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122400167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T16:20:52Z","timestamp":1718641252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197122400167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":10,"alternative-id":["S120197122400167X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107096","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid decrease in IL-1Ra and IP-10 plasma levels following tuberculosis treatment initiation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107096"}}